Provectus Pharmaceuticals Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Provectus Pharmaceuticals Inc.

PVCT 0.0600

+16.5%

Nov 26 3:10 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: jm2i123 who wrote (11385)	6/27/2012 5:08:37 PM
From: NTTG	2 Recommendations of 13111

Not true, have posted long commentary in the past, you probably just didn't read them. No frustration here, PVCT is going down the anticipated road...mouse MOA before human MOA, limited patient types and no aggressive disease patients for the PIII trial design....PVCT is being reigned in because they can not make their case with the experts. Stage IV patients are out, progressive disease is out...not what you want to see for a 'broad spectrum of activity' story

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next